These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17556636)

  • 1. The metabolism and toxicity of furosemide in the Wistar rat and CD-1 mouse: a chemical and biochemical definition of the toxicophore.
    Williams DP; Antoine DJ; Butler PJ; Jones R; Randle L; Payne A; Howard M; Gardner I; Blagg J; Park BK
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1208-20. PubMed ID: 17556636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactivation of isothiazoles: minimizing the risk of potential toxicity in drug discovery.
    Teffera Y; Choquette D; Liu J; Colletti AE; Hollis LS; Lin MH; Zhao Z
    Chem Res Toxicol; 2010 Nov; 23(11):1743-52. PubMed ID: 20825217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
    Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
    Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of hepatic metabolism in the bioactivation and detoxication of amodiaquine.
    Jewell H; Maggs JL; Harrison AC; O'Neill PM; Ruscoe JE; Park BK
    Xenobiotica; 1995 Feb; 25(2):199-217. PubMed ID: 7618347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells.
    Reilly CA; Ehlhardt WJ; Jackson DA; Kulanthaivel P; Mutlib AE; Espina RJ; Moody DE; Crouch DJ; Yost GS
    Chem Res Toxicol; 2003 Mar; 16(3):336-49. PubMed ID: 12641434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activation of troglitazone: identification of a reactive metabolite and mechanisms involved.
    He K; Talaat RE; Pool WF; Reily MD; Reed JE; Bridges AJ; Woolf TF
    Drug Metab Dispos; 2004 Jun; 32(6):639-46. PubMed ID: 15155556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of furan pharmacokinetics from hepatocyte studies: comparison of bioactivation and hepatic dosimetry in rats, mice, and humans.
    Kedderis GL; Held SD
    Toxicol Appl Pharmacol; 1996 Sep; 140(1):124-30. PubMed ID: 8806878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of trichloroethylene in isolated hepatocytes, microsomes, and reconstituted enzyme systems containing cytochrome P-450.
    Miller RE; Guengerich FP
    Cancer Res; 1983 Mar; 43(3):1145-52. PubMed ID: 6825087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the thiophene ring of methapyrilene as a novel bioactivation-dependent hepatic toxicophore.
    Graham EE; Walsh RJ; Hirst CM; Maggs JL; Martin S; Wild MJ; Wilson ID; Harding JR; Kenna JG; Peter RM; Williams DP; Park BK
    J Pharmacol Exp Ther; 2008 Aug; 326(2):657-71. PubMed ID: 18451316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation and protein binding of the acyl glucuronide of a leukotriene B4 antagonist (SB-209247): relation to species differences in hepatotoxicity.
    Kenny JR; Maggs JL; Tettey JN; Harrell AW; Parker SG; Clarke SE; Park BK
    Drug Metab Dispos; 2005 Feb; 33(2):271-81. PubMed ID: 15523047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propiconazole increases reactive oxygen species levels in mouse hepatic cells in culture and in mouse liver by a cytochrome P450 enzyme mediated process.
    Nesnow S; Grindstaff RD; Lambert G; Padgett WT; Bruno M; Ge Y; Chen PJ; Wood CE; Murphy L
    Chem Biol Interact; 2011 Oct; 194(1):79-89. PubMed ID: 21864511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactivation of 2,3-diaminopyridine-containing bradykinin B1 receptor antagonists: irreversible binding to liver microsomal proteins and formation of glutathione conjugates.
    Tang C; Subramanian R; Kuo Y; Krymgold S; Lu P; Kuduk SD; Ng C; Feng DM; Elmore C; Soli E; Ho J; Bock MG; Baillie TA; Prueksaritanont T
    Chem Res Toxicol; 2005 Jun; 18(6):934-45. PubMed ID: 15962928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactivation of coumarin in rat olfactory mucosal microsomes: Detection of protein covalent binding and identification of reactive intermediates through analysis of glutathione adducts.
    Zhuo X; Zhao W; Zheng J; Humphreys WG; Shu YZ; Zhu M
    Chem Biol Interact; 2009 Oct; 181(2):227-35. PubMed ID: 19576871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans.
    Masubuchi N; Makino C; Murayama N
    Chem Res Toxicol; 2007 Mar; 20(3):455-64. PubMed ID: 17309281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport, metabolism, and hepatotoxicity of flutamide, drug-drug interaction with acetaminophen involving phase I and phase II metabolites.
    Kostrubsky SE; Strom SC; Ellis E; Nelson SD; Mutlib AE
    Chem Res Toxicol; 2007 Oct; 20(10):1503-12. PubMed ID: 17900172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro metabolic activation of thiabendazole via 5-hydroxythiabendazole: identification of a glutathione conjugate of 5-hydroxythiabendazole.
    Dalvie D; Smith E; Deese A; Bowlin S
    Drug Metab Dispos; 2006 Apr; 34(4):709-17. PubMed ID: 16434547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential metabolism of 1,1-dichloroethylene in livers of A/J, CD-1, and C57BL/6 mice.
    Forkert PG; Boyd SM
    Drug Metab Dispos; 2001 Nov; 29(11):1396-402. PubMed ID: 11602514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of in vitro data for construction of a physiologically based pharmacokinetic model for naphthalene in rats and mice to probe species differences.
    Quick DJ; Shuler ML
    Biotechnol Prog; 1999; 15(3):540-55. PubMed ID: 10356275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism for isaxonine hepatitis. II. Protective role of glutathione and toxicological studies in mice.
    Fouin-Fortunet H; Lettéron P; Tinel M; Degott C; Flejou JF; Pessayre D
    J Pharmacol Exp Ther; 1984 Jun; 229(3):851-8. PubMed ID: 6547180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative CYP-dependent binding of the adrenocortical toxicants 3-methylsulfonyl-DDE and o,p'-DDD in Y-1 adrenal cells.
    Hermansson V; Asp V; Bergman A; Bergström U; Brandt I
    Arch Toxicol; 2007 Nov; 81(11):793-801. PubMed ID: 17487473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.